In TFEB-rearranged renal cell carcinoma, cathepsin K staining is confirmed to be reliable, with strong and diffuse immunolabelling in the neoplastic cells, regardless of the fusion partner gene, such as MALAT1, ACTB, and NEAT1 [30]. This evidence concerns the gene TFEB and hereditary clear cell renal cell carcinoma.